dsm-firmenich received approximately €1.4 billion net in cash, after transaction costs
dsm-firmenich, innovators in nutrition, health, and beauty, today announces the successful completion of the sale of its stake in the Feed Enzymes Alliance to its partner Novonesis, a global leader in biosolutions, for €1.5 billion. The sale agreement was announced on February 11, 2025.
dsm-firmenich received approximately €1.4 billion net in cash, after transaction costs.
Subscribe to our newsletter & stay updated.
